MANCINI, MANUELA

MANCINI, MANUELA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Assegnisti  

M. Mancini; Manuela Mancini; Mancini M; Mancini  

Risultati 1 - 20 di 66 (tempo di esecuzione: 0.033 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia Mancini, Manuela; Leo, Elisa; Takemaru, Ken-Ichi; Campi, Virginia; Castagnetti, Fausto; Soverini, Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni 2015-01-01 PLOS ONE - 1.01 Articolo in rivista Mancini_PONE_2015.pdfpone.0131074.s001.pdfpone.0131074.s002.pdfpone.0131074.s003.pdfpone.0131074.s004.pdfpone.0131074.s004.pdf
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias Corradi V.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A.; Schenone S.; Botta M. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. Malagola M; Skert C; Vignetti M; Piciocchi A; Martinelli G; Alimena G; Mecucci C; Testoni N; Iacobucci I; Clavio M; Gobbi M; Candoni A; Damiani D; Bocchia M; Lauria F; Zaccaria A; Mazza P; Visani G; Peli A; Colombi C; Cancelli V; Mancini M; Fo R; Martelli M; Cantore N; Raimondo FD; Petrini M; de Fabritiis P; Fioritoni G; Nobile F; Fabbiano F; Specchia G; Baccarani M; Coco FL; Amadori S; Mandelli F; Russo D. 2011-01-01 LEUKEMIA & LYMPHOMA - 1.01 Articolo in rivista -
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl Mancini M.; Zuffa E.; Corrado P.; Brusa G.; Petta S.; Pagnotta E.; Santucci M.A. 2006-01-01 - s.n 4.02 Riassunto (Abstract) -
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. Leo E;Mancini M;Aluigi M;Luatti S;Castagnetti F;Testoni N;Soverini S;Santucci MA;Martinelli G 2013-01-01 PLOS ONE - 1.01 Articolo in rivista Leo et al_PONE2013.pdf
Best practices in chronic myeloid leukemia monitoring and management Soverini, S; De Benedittis, C; Mancini, M; Martinelli, G. 2016-01-01 THE ONCOLOGIST - 1.01 Articolo in rivista -
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. Santucci MA; Corradi V; Mancini M; Manetti F; Radi M; Schenone S; Botta M. 2009-01-01 CHEMMEDCHEM - 1.01 Articolo in rivista -
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib Manuela Mancini;Elisa Leo;Virginia Campi;Fausto Castagnetti;Luca Zazzeroni;Gabriele Gugliotta;Maria Alessandra Santucci;Giovanni Martinelli 2014-01-01 CELLULAR SIGNALLING - 1.01 Articolo in rivista -
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S. 2021-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista -
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia Mancini, Manuela; Soverini, Simona; Gugliotta, Gabriele; Santucci, MARIA ALESSANDRA; Rosti, Gianantonio; Cavo, Michele; Martinelli, Giovanni; Castagnetti, Fausto 2017-01-01 ONCOTARGET - 1.01 Articolo in rivista -
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells Manuela Mancini;Elisa Leo;Ken-Ichi Takemaru;Virginia Campi;Enrica Borsi;Fausto Castagnetti;Gabriele Gugliotta;Maria Alessandra Santucci;Giovanni Martinelli 2013-01-01 CELLULAR SIGNALLING - 1.01 Articolo in rivista -
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy Soverini, Simona; Mancini, Manuela; Bavaro, Luana; Cavo, Michele; Martinelli, Giovanni 2018-01-01 MOLECULAR CANCER - 1.01 Articolo in rivista document.pdf
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients Soverini, S; De Benedittis, C; Papayannidis, C; Polakova, K Machova; Venturi, C; Russo, D; Bresciani, P; Iurlo, A; Mancini, M; Vitale, A; Chiaretti, S; Foà, R; Abruzzese, E; Sorà, F; Kohlmann, A; Haferlach, T; Baccarani, M; Cavo, M; Martinelli, G 2016-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-00738.pdfcancers-14-00738-s001.zip
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) M. Mancini; G. Brusa; A. Calabrò; N. Calonghi; E. Pagnotta; M. Alessandra Santucci; L. Masotti 2004-01-01 - Graphital 4.01 Contributo in Atti di convegno -
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia Manuela Mancini;Nevena Veljkovic;Elisa Leo;Michela Aluigi;Enrica Borsi;Chiara Galloni;Ilaria Iacobucci;Enza Barbieri;Maria Alessandra Santucci 2012-01-01 JOURNAL OF CELLULAR BIOCHEMISTRY - 1.01 Articolo in rivista -
Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G. 2013-01-01 HAEMATOLOGICA - 1.06 Abstract in rivista -
Deletionsof the derivative chromosome 9 do not influence the response and the outcomeof chronic myeloid leukemia in early chronic phase treated with imatinibmesylate: GIMEMA CML Working Party analysis Castagnetti F; Testoni N;Luatti S; Marzocchi G; Mancini M; Kerim S; Giugliano E; Albano F; Cuneo A;Abruzzese E; Martino B; Palandri F; Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G 2010-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Radi M; Crespan E; Botta G; Falchi F; Maga G; Manetti F; Corradi V; Mancini M; Santucci MA; Schenone S; Botta M. 2008-01-01 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS - 1.01 Articolo in rivista -
DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia Leo E.; Mancini M.; Aluigi M.; Castagnetti F.; Martinelli G.; Barbieri E.; Santucci MA. 2012-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -